Valeant Pharmaceuticals is being accused of an Enron-like fraud.
Short selling firm Citron Research released a report highlighting its mysterious relationship with Philador, a pharmacy that distributes drugs for specialty pharmacies, which it has the option to purchase.
Read Full Article »